THC Biomed Intl Ltd.
THCBF
$0.00
$0.000.00%
OTC PK
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.68M | 1.79M | 1.69M | 1.92M | 1.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.68M | 1.79M | 1.69M | 1.92M | 1.96M |
| Cost of Revenue | 2.56M | 2.55M | 2.92M | 2.72M | 2.73M |
| Gross Profit | -880.00K | -765.00K | -1.23M | -801.10K | -769.30K |
| SG&A Expenses | 1.21M | 1.19M | 1.18M | 1.32M | 1.39M |
| Depreciation & Amortization | 648.90K | 688.70K | 716.00K | 731.40K | 743.30K |
| Other Operating Expenses | 400.00 | 5.00K | 11.00K | 17.10K | 27.80K |
| Total Operating Expenses | 4.42M | 4.43M | 4.82M | 4.79M | 4.89M |
| Operating Income | -2.74M | -2.65M | -3.14M | -2.87M | -2.93M |
| Income Before Tax | -2.77M | -2.19M | -2.67M | -2.40M | -2.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.77 | -2.19 | -2.67 | -2.40 | -2.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.77M | -2.19M | -2.67M | -2.40M | -2.47M |
| EBIT | -2.74M | -2.65M | -3.14M | -2.87M | -2.93M |
| EBITDA | -2.07M | -2.06M | -2.52M | -2.19M | -2.43M |
| EPS Basic | -0.02 | -0.01 | -0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | -0.02 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 655.75M | 655.75M | 655.71M | 655.61M | 660.71M |
| Average Diluted Shares Outstanding | 655.75M | 655.75M | 655.71M | 655.61M | 660.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |